Decline depth
-33.5%
From rolling 252-day high of $23.87, 125d ago.
Past the 30% Amber threshold.
-33.5%
from rolling 252-day high of $23.87 set 2026-01-23 · 125d ago
Current
$15.87
Decline depth
-33.5%
Decline σ
7.2σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$ALHC landed on the list 2026-03-03, down 22.7% from its 52-week high that day — now down -33.5%.
That's 12.9 percentage points deeper than the day it joined. It bottomed 44.3% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-03 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
ALHC qualifies for the Amber List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
7.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.18% per day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about ALHC.
ALHC qualifies for the Amber List on decline depth — down -33.5% from its rolling 252-day high.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 7.2σ over 20 bars.
Earnings on file: 2026-02-26. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $11.62
34.6% of range
52W high $23.87
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
89
Red List
46
Amber
59
Watch
-36.0%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to ALHC
Amber ListRecovering
STVN
Stevanato Group S.p.A.
Red ListRecovering
VNDA
Vanda Pharmaceuticals Inc.
Amber ListRecovering
MLYS
Mineralys Therapeutics, Inc.
Amber ListRecovering
AGIO
Agios Pharmaceuticals, Inc.
Red List
INBX
Inhibrx Biosciences, Inc.
Red List
MMSI
Merit Medical Systems, Inc.
Questions about ALHC
What people ask.
Why is ALHC on Broken Stocks?
ALHC qualifies for the Amber List on decline depth. It is down -33.5% from its rolling 252-day high of $23.87, set on 2026-01-23 — 125d ago.
Is ALHC a falling knife?
Not by the strict technical definition. ALHC is down -33.5% from its 52-week high, but that high was set 125d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ALHC is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is ALHC a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ALHC trading inside its 52-week range?
At $15.87, ALHC sits 34.6% of the way from its 52-week low ($11.62) to its 52-week high ($23.87). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ALHC been declining?
The current 33.5% decline accrued over 125d, which annualizes to roughly -97.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ALHC compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -36.0% — ALHC's decline is shallower than the sector median.
Does ALHC's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-26) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.